Fundraising FoxAblative Solutions
Wakefield, US · Founded 2011 · Delaware corporation · 4 known investors
Find your way into Ablative Solutions
Sign up to see every warm intro you have to Ablative Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ablative Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Ablative Solutions was founded in 2011 by Tim A. Fischell.
TA
Tim A. FischellFounderTim Fischell is a research director with background in the medical device industry, holding expertise in vascular devices, biotechnology, and emergency medicine. He holds a degree from Stanford University and serves as Executive Officer and Director at Ablative Solutions.
KR
Kate RumrillExecutive
LM
Lisa MastromatteiExecutive
RD
Ronald D BacheExecutive
VE
Vartan E. GhazarossianExecutive
DR
David R. FischellNamed on SEC filing
Board
LC
GP
NH
Nathan HarringtonBoard director
JK
DG
PB
Paul BuckmanBoard director
Investors · 4
BioStar VenturesreportedPetoskey
How we know: funding news · Not right? Tell us
Gilde HealthcarereportedUtrecht · $1.1M – $55M
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$166.9M disclosed across 12 of 13 rounds · 2011–2025
- Undisclosed amountSeries DJun 2022Source ↗
▶$10.4MraisedNov 2025 · 10 investors · Other Health CareRule 506(b)
▶$10.4MraisedNov 2025 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ronald D. BacheExecutive Officer, Director
- Louis CannonDirector
- John KerschenDirector
- Geoff PardoDirector
- Brian RaulsExecutive Officer
- Benjamin TsaiDirector
- Offering amount
- $45M
- Amount sold
- $10.4M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$37.2MraisedDec 2024 · 88 investors · Other Health CareRule 506(b)
▶$37.2MraisedDec 2024 · 88 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kate RumrillExecutive Officer, Director
- Lisa MastromatteiExecutive Officer
- David R FischellDirector
- Louis CannonDirector
- Geoff PardoDirector
- Paul BuckmanDirector
- Ronald D BacheExecutive Officer, Director
- Nathan HarringtonDirector
- John KerschenDirector
- Offering amount
- $45.5M
- Amount sold
- $37.2M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.3MraisedJan 2024 · 121 investors · Other Health CareRule 506(b)
▶$29.3MraisedJan 2024 · 121 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael FultonDirector
- Paul BuckmanDirector
- David R. FischellDirector
- John KerschenDirector
- Andrew TochtermanDirector
- Kate RumrillExecutive Officer, Director
- Lisa MastromatteiExecutive Officer
- Geoff PardoDirector
- Ronald D. BacheDirector
- Offering amount
- $30M
- Amount sold
- $29.3M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$54.5MraisedFeb 2021 · 105 investors · Other Health CareRule 506(b)
▶$54.5MraisedFeb 2021 · 105 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David R. FischellDirector
- John KerschenDirector
- Paul BuckmanDirector
- Geoff PardoDirector
- Andrew TochtermanDirector
- Kate RumrillExecutive Officer, Director
- Lisa MastromatteiExecutive Officer
- Michael FultonDirector
- Offering amount
- $91.5M
- Amount sold
- $54.5M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJan 2018 · 24 investors · Other Health CareRule 506(b)
▶$4MraisedJan 2018 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Phillip D. TorrenceExecutive Officer
- Nicole HarataniExecutive Officer
- Steven L. AlmanyDirector
- Dale GroganDirector
- Paul BuckmanDirector
- Tim A. FischellExecutive Officer, Director
- David R. FischellExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $4M
- Minimum investment
- $10K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.4MraisedMar 2017 · 88 investors · Other Health CareRule 506(b)
▶$11.4MraisedMar 2017 · 88 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicole HarataniExecutive Officer
- Phillip D. TorrenceExecutive Officer
- Paul BuckmanDirector
- David R. FischellExecutive Officer, Director
- Steven L. AlmanyDirector
- Dale GroganDirector
- Tim A. FischellExecutive Officer, Director
- Offering amount
- $15.8M
- Amount sold
- $11.4M
- Minimum investment
- $25K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedNov 2015 · 24 investors · Other Health CareRule 506(b)
▶$2.5MraisedNov 2015 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dale GroganDirector
- David K. RosenDirector
- Tim A. FischellExecutive Officer, Director
- Phillip D. TorrenceExecutive Officer
- Vartan E. GhazarossianExecutive Officer, Director
- Steven L. AlmanyDirector
- David R. FischellExecutive Officer, Director
- Offering amount
- $6.5M
- Amount sold
- $2.5M
- Minimum investment
- $25K
- Proceeds to insiders
- $25K
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$14.6MraisedJan 2015 · 149 investors · Other Health CareRule 506(b)
▶$14.6MraisedJan 2015 · 149 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dale GroganDirector
- Steven L. AlmanyDirector
- David K. RosenDirector
- Vartan E. GhazarossianExecutive Officer, Director
- Tim A. FischellExecutive Officer, Director
- David R. FischellExecutive Officer, Director
- Phillip D. TorrenceExecutive Officer
- Offering amount
- $18M
- Amount sold
- $14.6M
- Proceeds to insiders
- $375K
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Ablative Solutions.
In the news
Frequently asked questions
- Who founded Ablative Solutions?
- Ablative Solutions was founded by Tim A. Fischell in 2011.
- Who are Ablative Solutions's investors?
- Ablative Solutions's investors include Michigan Capital Network, BioStar Ventures, Gilde Healthcare, MAF.
- How much funding has Ablative Solutions raised?
- Ablative Solutions has disclosed $166.9M raised across 12 of its 13 known rounds.
- Where is Ablative Solutions headquartered?
- Ablative Solutions is headquartered in Wakefield, US.